Global Blood Therapeutics, Inc.
GBT · NASDAQ
6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$82,470 | -$81,423 | -$87,581 | -$70,988 |
| Dep. & Amort. | $2,305 | $2,265 | $2,218 | $2,189 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $19,842 | $19,142 | $19,406 | $18,080 |
| Change in WC | $16,874 | -$14,325 | -$2,554 | -$14,846 |
| Other Non-Cash | -$859 | $2,488 | $585 | $255 |
| Operating Cash Flow | -$44,308 | -$71,853 | -$67,926 | -$65,310 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$384 | -$252 | -$1,053 | -$260 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$163,777 | -$222,248 | -$19,658 | -$30,695 |
| Inv. Sales/Matur. | $29,500 | $0 | $3,200 | $14,826 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$134,661 | -$222,500 | -$17,511 | -$16,129 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $48,495 | $0 | $2,070 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $48,597 | $1,602 | $387,171 | $45,092 |
| Financing Cash Flow | $48,597 | $1,602 | $387,171 | $45,092 |
| Forex Effect | -$299 | -$147 | $99 | -$39 |
| Net Chg. in Cash | -$130,671 | -$292,898 | $301,833 | -$36,386 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $394,255 | $687,153 | $385,320 | $421,706 |
| End Cash | $263,584 | $394,255 | $687,153 | $385,320 |
| Free Cash Flow | -$44,692 | -$72,105 | -$68,979 | -$65,570 |